Meek David D. Insider Trades

Insider Trading History

Track insider trading activity for Meek David D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $957k 34,190 shares
Last Trade
Jun 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.5k 2,112 shares
$14.45
$27.99
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $556k 38,513 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 38,513 shares
$8.95
$14.43
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $1.02M 36,302 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 15,630 shares
$16.22
$27.99
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $793k 28,332 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.4k 15,840 shares
$4.57
$27.99
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $567k 20,252 shares
Last Trade
Jun 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.4k 2,229 shares
$5.12
$27.99
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $0 0 shares
Last Trade
Jun 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$733k 34,000 shares
$21.55
$21.55
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $225k 15,618 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 15,618 shares
$26.72
$14.43
Fusion Pharmaceuticals
Fusion Pharmaceuticals FUSN
Director
Holding Value $733k 34,000 shares
Last Trade
Oct 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 34,000 shares
$4.16
$21.55
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $629k 22,481 shares
Last Trade
Jun 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.2k 2,290 shares
$18.85
$27.99
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $693k 24,771 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$344k 17,060 shares
$20.18
$27.99
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $450k 16,071 shares
Last Trade
Feb 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.67k 389 shares
$19.71
$27.99
Mirati Therapeutics
Mirati Therapeutics MRTX
Director, Chief Executive Officer
Holding Value $8.88M 151,233 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11M 240,612 shares
$45.66
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director, Chief Executive Officer
Holding Value $3.63M 61,792 shares
Last Trade
Jan 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$135k 3,179 shares
$42.38
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director, Chief Executive Officer
Holding Value $3.81M 64,971 shares
Last Trade
Dec 21, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$187k 4,616 shares
$40.41
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director, Chief Executive Officer
Holding Value $4.08M 69,587 shares
Last Trade
Dec 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 35,425 shares
$41.43
$58.70
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$62k 28,307 shares
$2.19
$2.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$60.5k 27,500 shares
$2.20
$2.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
Director
Holding Value $0 0 shares
Last Trade
Jul 07, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$48.4k 22,000 shares
$2.20
$2.19
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $499k 17,810 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 17,810 shares
$14.08
$27.99
uniQure N.V.
uniQure N.V. QURE
Director
Holding Value $207k 7,380 shares
Last Trade
Feb 28, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.1k 602 shares
$16.70
$27.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up